Holger Lenz, Emerging Science & Innovation Director Dermatology at Bayer, discussed with us the interest of Bayer in the microbiome space during the Microbiome Connect: Europe 2022.
MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome
Published by Clorofilla Srl
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED